3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
7
Phase 4
3
Phase 2
3
Phase 2/3
2
Status
Completed
3
Unknown
2
Active not recruiting
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
1
Breast
1
Conditions
Osteosarcoma
1
Breast Neoplasms
1
Interventions
Cisplatin
20
Docetaxel
19
Capecitabine
19
Oxaliplatin
14
Drug Therapy
14
Cyclophosphamide
14
Paclitaxel
13
Fluorouracil
12
Radiotherapy
11
apatinib
9
Gemcitabine
9
Doxorubicin
9
Decitabine
9
Methotrexate
8
Epirubicin
8
Carboplatin
8
sintilimab
6
Etoposide
6
camrelizumab
5
anlotinib
5
XELOX
5
Sorafenib
5
Radiation
5
Pemetrexed
5
Neoadjuvant Therapy
5
Leucovorin
5
Idarubicin
5
Dexamethasone
5
Cytarabine
5
Busulfan
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
Unknown
×
Zoledronic Acid
×
Clear all
NCT01654367
2012-07-31
esozao
Tianjin Medical University
Phase 2/3
Unknown
300 enrolled
NCT00691236
2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3
Unknown
60 enrolled